RAP 3.57% 14.5¢ resapp health limited

It was first developed for paediatric so they've gathered more...

  1. 2,044 Posts.
    lightbulb Created with Sketch. 42
    It was first developed for paediatric so they've gathered more data and done more testing, then it was extend to Adult only a 12-18 months (likely just to see if it could) and that also showed very good diagnosis accuracy.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.